about
All-atom model for stabilization of alpha-helical structure in peptides by hydrocarbon staples.Potent D-peptide inhibitors of HIV-1 entryPeptide inhibitors of dengue virus and West Nile virus infectivitySynthetic Peptides as Protein MimicsStructural and biological mimicry of protein surface recognition by / -peptide foldamersDesign of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to ResistanceCrystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41Chimeric Glutathione S-Transferases Containing Inserts of Kininogen Peptides: POTENTIAL NOVEL PROTEIN THERAPEUTICSOxime side-chain cross-links in an α-helical coiled-coil protein: structure, thermodynamics, and folding-templated synthesis of bicyclic speciesA general strategy to endow natural fusion-protein-derived peptides with potent antiviral activityDual-purpose linker for alpha helix stabilization and imaging agent conjugation to glucagon-like peptide-1 receptor ligands.Comparative α-helicity of cyclic pentapeptides in water.A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1Contemporary strategies for the stabilization of peptides in the alpha-helical conformation.Stable extended human immunodeficiency virus type 1 gp41 coiled coil as an effective target in an assay for high-affinity fusion inhibitors.Inhibiting HIV fusion with a beta-peptide foldamer.Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeuticA human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitopeDiscovery of entry inhibitors for HIV-1 via a new de novo protein design framework.Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics.Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactionsHIPdb: a database of experimentally validated HIV inhibiting peptides.A readily applicable strategy to convert peptides to peptoid-based therapeutics.Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloadditionIncreasing hydrophobicity of residues in an anti-HIV-1 Env peptide synergistically improves potencyDisruption of Bcr-Abl coiled coil oligomerization by design.Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor designProtein grafting of an HIV-1-inhibiting epitopeDesign of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virusChicken heat shock protein 90 is a component of the putative cellular receptor complex of infectious bursal disease virusProgress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1.Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtideA Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.Helix-mediated protein--protein interactions as targets for intervention using foldamers.Amphipathic properties of HIV-1 gp41 fusion inhibitors.
P2860
Q24645116-0B294863-51E9-4592-9683-3FDFF50AC353Q24675493-E6036083-8F37-4EC3-B40E-D993F790329BQ24813811-38D95DAE-9229-48D7-B010-C4A654A550ABQ26770255-D6E3F703-F0BB-4C7D-AF46-518F4315E88DQ27657158-4E5D4C05-9AEB-4D1B-8139-57C5B61AE53BQ27664086-D4010974-AA16-400A-9D5C-5243B0E13813Q27666159-BD6047A4-13E9-4D7B-9DCC-00F6BDC125F8Q27679018-B0BF7065-439D-49F4-9860-541066F2446FQ27685194-D9AFB6B6-D372-471C-B6A8-38C63A1B088CQ28729918-EF184782-1E53-4605-AFA1-A8557DDBC992Q30379845-89F81DAF-07CE-4578-BF4F-BB55DF0543D9Q30820760-C559B69A-C704-4CD2-B29E-2D0A41086001Q33239507-0B6E0027-9F9F-4B59-BCEE-2B6EA8F55FD2Q33282526-8E0A8153-EAC5-4A9E-8BDA-0A7BD46CD986Q33369664-618C22FF-60DD-46ED-9A0F-F5905AD74891Q33429777-38E5B5D8-777B-4F8D-A155-EBEC77D33E5AQ33862300-C3BF84EA-23A3-41E4-A403-8A9D1F83FFBBQ33951142-6C6124A1-C538-418D-BC17-5B4A3E0EDB1FQ34069846-0FAE102C-20F5-4FF2-B422-DFE7C362F91DQ34078521-F136FBAC-924D-41C4-977E-7E1261C44E1FQ34150117-C7C5C691-88DB-4F5D-86FA-6980731568C2Q34253106-7BDA46F4-D8DB-42EA-B83A-EC3FF9F59B35Q34281656-2FEBD869-953C-4C52-85C0-52A1A5AF5437Q34522767-D7C97812-0143-41E2-9CB4-50D43406477AQ34566584-398B38BD-4A37-4719-BF98-7BE43E0FFBDDQ34650581-1F4E71D5-53F6-44AD-AAB6-4A286957854CQ34670518-C87BF72E-4D17-443C-A261-972145824BCCQ34800822-F17D8058-A4DC-4D8E-BD8E-F7C1A1EC129EQ35145034-28FDF570-5A7A-4F4B-A828-B72F99209AFBQ35563298-CFCDE302-C4D5-4860-879E-CD2C6B196607Q35813478-2392C50C-73E1-427A-A7ED-F8A7ABFC95CFQ35921668-F41927B6-0A2B-45C3-A32D-0134DCB6982CQ35947841-BC65549B-A0FA-46DE-9D8D-F25AF63D056CQ36458359-B7AF987B-8BD9-47FB-A8BB-D7AFBEAEA0D7Q36972346-F700B642-556D-4184-BE2E-5F4B3A500D03Q37115773-53F7B405-D49B-4520-893C-C5F12B8A9A4DQ37116075-B2883F6B-D6BF-4184-AC0F-9BA6A594E95BQ37720808-A8CD43F4-5278-4CC9-9942-3C4ABA9E8449Q37853442-F79D7502-B16C-49A3-AB9E-A83B0F5F6619Q37951610-11825CF0-50FA-41F9-84CC-6C6B3029ABBB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Short constrained peptides that inhibit HIV-1 entry
@ast
Short constrained peptides that inhibit HIV-1 entry
@en
Short constrained peptides that inhibit HIV-1 entry
@nl
type
label
Short constrained peptides that inhibit HIV-1 entry
@ast
Short constrained peptides that inhibit HIV-1 entry
@en
Short constrained peptides that inhibit HIV-1 entry
@nl
prefLabel
Short constrained peptides that inhibit HIV-1 entry
@ast
Short constrained peptides that inhibit HIV-1 entry
@en
Short constrained peptides that inhibit HIV-1 entry
@nl
P2093
P2860
P356
P1476
Short constrained peptides that inhibit HIV-1 entry
@en
P2093
Peter A Carr
Peter S Kim
Samuel K Sia
Vladimir N Malashkevich
P2860
P304
14664-14669
P356
10.1073/PNAS.232566599
P407
P577
2002-11-04T00:00:00Z